Finance

Beta
Lists
FBRX:NASDAQ
Forte Biosciences Inc
$16.52
-1.02%
(-0.17) 1D
$16.52
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBRX...
Open
$16.37
High
$16.70
Low
$15.71
Mkt. cap
338.31M
Avg. vol.
236.47K
Volume
408.71K
52-wk high
$35.80
52-wk low
$9.12
EPS
-$4.58
Beta
2.87
Shares outstanding
20.48M
No. of employees
22
Open
$16.37
High
$16.70
Low
$15.71
Mkt. cap
338.31M
Avg. vol.
236.47K
Volume
408.71K
52-wk high
$35.80
52-wk low
$9.12
EPS
-$4.58
Beta
2.87
Shares outstanding
20.48M
No. of employees
22
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to FBRX in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for FBRX in the last 3 months.
Highest
Current $16.52
$75.00 (+354.00%)
Average
$67.00 (+305.57%)
Lowest
$61.00 (+269.25%)
News stories
From sources across the web
About Forte Biosciences Inc
CEO-
Employees22
Founded2007
HeadquartersDallas, Texas, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.62M
15.20M
21.74M
20.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.96M
3.18M
2.84M
1.97M
Operating expense
11.58M
18.38M
24.57M
22.44M
Total operating expenses
11.58M
18.38M
24.57M
22.44M
Operating income
-11.58M
-18.38M
-24.57M
-22.44M
Other non operating income
330.00K
701.00K
-1.65M
676.00K
EBT including unusual items
-11.25M
-17.68M
-23.75M
-21.76M
EBT excluding unusual items
-11.25M
-17.68M
-23.50M
-21.76M
Income tax expense
-
-
1.04M
373.00K
Effective tax rate
-
-
-4.37%
-1.71%
Other operating expenses
-
-
-
-
Net income
-11.25M
-17.68M
-24.79M
-22.14M
Net profit margin
-
-
-
-
Earnings per share
-0.96
-0.99
-1.45
-1.24
Interest and investment income
-
-
2.72M
-
Interest expense
-
-
-
-
Net interest expenses
-
-
2.72M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.56M
-18.37M
-24.55M
-22.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more